Skip to main content
OpenTrials

Clinical trial condition

Systemic Lupus Erythematosus

Explore clinical trials studying Systemic Lupus Erythematosus. Study availability and eligibility vary by location and protocol.

484 public trials 113 recruiting studies
Refine in advanced search Browse all conditions

Systemic Lupus Erythematosus trial results

Recruiting

RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus

NCT06121297

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +12 more
Locations
  • University of California Irvine Orange, California, United States
  • UC Davis Health Sacramento, California, United States
  • Yale University New Haven, Connecticut, United States
  • University of Florida Health Gainesville, Florida, United States
View all 23 locations
View Trial Details
Recruiting

A Phase 1b Study of Budoprutug in Systemic Lupus Erythematosus (SLE)

NCT07011043

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +3 more
Locations
  • Climb Bio Investigative Site #100104 Allen, Texas, United States
  • Climb Bio Investigative Site #100101 San Antonio, Texas, United States
  • Climb Bio Investigative Site# 359101 Plovdiv, Bulgaria
  • Climb Bio Investigative Site# 359102 Sofia, Bulgaria
View all 18 locations
View Trial Details
Recruiting

Obe-cel in Adolescent [Applicable in UK Only] and Adult Severe, Refractory Systemic Lupus Erythematosus

NCT06333483

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +3 more
Locations
  • Hospital Universitari Vall Hebrón Barcelona, Spain
  • Hospital Universitari i Politecnic La Fe Valencia, Spain
  • Addenbrookes Hospital Cambridge, United Kingdom
  • University College London Hospitals NHS Foundation Trust London, United Kingdom
View Trial Details
Recruiting

Effects of Stopping Hydroxychloroquine in Elderly Lupus Disease

NCT05799378

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +3 more
Locations
  • University of California, Los Angeles Los Angeles, California, United States
  • Hackensack Meridian Health Hackensack, New Jersey, United States
  • VA NY Harbor Healthcare System New York, United States
  • NYC Health + Hospitals/Bellevue New York, United States
View Trial Details

Related conditions